1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid assessment of mono and combo targeted and immune therapies using a biorepository of fresh patient tumoroids with intact tumor microenvironment
Biomarkers, Immune Monitoring and Novel Technologies
1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid assessment of mono and combo targeted and immune therapies using a biorepository of fresh patient tumoroids with intact tumor microenvironment